← Leaderboards
Zakary Singer
Columbia Univ New York Morningside
$191,090
Attributed
$191,090
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $69.3K · FY2018–20$100K$75K$50K$25K$0
'18
'19
'20
Funding mix
By agency
NIH$191,090 · 1
By mechanism
F32$191,090 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia Univ New York Morningside
Same institution · by research overlap
- Tal Danino$10,808,082
- Nicholas Arpaia$10,668,029
- Bentley M. Shuster$150,669
- Phillip L Marotta$526,870
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesBacteriaBalb/C Nude MouseBeneficial MicroorganismBiological ModelsCancer CellCancer EtiologyCellsCessation Of LifeChemotherapyChronicCirrhosisColorectalCommunitiesCurative TreatmentsCytolysisCytotoxicDetectionDiagnosisDna Sequence AlterationEngineered ProbioticsEngineeringEscherichia ColiAffect
Grant awards (3)
Engineering of bacterial probiotics for the detection and treatment of hepatocellular carcinoma$69,306
F32 · FY2020 · CA · contact PI
Engineering of bacterial probiotics for the detection and treatment of hepatocellular carcinoma$62,746
F32 · FY2019 · CA · contact PI
Engineering of bacterial probiotics for the detection and treatment of hepatocellular carcinoma$59,038
F32 · FY2018 · CA · contact PI